inVentiv Health
CRO inVentiv Health has appointed Michael McKelvey as Executive Vice President and President of its Clinical Division.
“Mike McKelvey has proven himself to be a hands-on leader who builds dynamic teams to tackle some of the most critical drug development issues facing the industry,” said Jeffrey McMullen, Vice Chairman. “His vision is to incorporate innovation into the current drug development process by providing clients with an outsourcing model that embeds both clinical and commercial services.”
McKelvey has a long career in the CRO industry, including senior positions at trial design firm Aptiv Solutions, later acquired by ICON.
He has also served as CEO of eResearchTechnology and led PAREXEL’s Phase II-IV studies in North and South America.